多参数MRI预测根治性前列腺切除术后Gleason评分升级与降级:与术前活检对比
本研究回顾性收集2015年1月至2021年12月219例前列腺疾病患者的临床与mpMRI资料,所有患者均行系统前列腺活检后接受根治性前列腺切除术。多变量logistic回归模型显示,联合临床因素与mpMRI所见预测术后Gleason评分升级的AUC为0.816、降级的AUC为0.883,均优于单用临床因素(P < 0.001)。结论认为联合临床因素与mpMRI所见能比单用临床因素更准确地预测根治性前列腺切除术后Gleason评分升级与降级。
要点
- 联合模型预测Gleason评分升级AUC 0.816,优于单用临床因素(P < 0.001)。
- 联合模型预测Gleason评分降级AUC 0.883,优于单用临床因素(P < 0.001)。
- mpMRI模型预测升级AUC 0.749、降级AUC 0.835,纳入PCa位置与PI-RADS v2.1评分。
核心结论
- 联合临床因素与mpMRI所见预测根治性前列腺切除术后Gleason评分升级与降级,比单用临床因素更准确。
研究设计与样本
- 回顾性收集2015年1月至2021年12月219例前列腺疾病患者的临床与mpMRI资料,所有患者均行系统前列腺活检后接受根治性前列腺切除术。
- mpMRI包括常规扩散加权成像与动态对比增强成像。
- 采用多变量logistic回归分析筛选与术后Gleason评分升级和降级相关的因素,并以受试者工作特征曲线分析评估模型预测升级与降级的AUC。
诊断标准与关键数值
- 预测Gleason评分升级:临床模型(阳性活检针数百分比、活检至根治性前列腺切除术时间)AUC 0.714,mpMRI模型(前列腺癌位置、PI-RADS v2.1评分)AUC 0.749,联合诊断模型(年龄、阳性活检针数百分比、tPSA、前列腺癌位置、PI-RADS v2.1评分)AUC 0.816,联合模型大于单用临床因素(P < 0.001)。
- 预测Gleason评分降级:临床模型(年龄、阳性活检针数百分比、游离/总PSA比值)AUC 0.749,mpMRI模型(前列腺癌直径、前列腺癌位置、PI-RADS v2.1评分)AUC 0.835,联合诊断模型(年龄、阳性活检针数百分比、游离/总PSA比值、前列腺癌直径、前列腺癌位置、PI-RADS v2.1评分)AUC 0.883,联合模型大于单用临床因素(P < 0.001)。
- 根治性前列腺切除术后Gleason评分升级92例、降级43例、不变84例。
临床应用与阅片要点
- 阅片时可关注前列腺癌位置、前列腺癌直径与PI-RADS v2.1评分,这些mpMRI指标被纳入预测术后Gleason评分升级或降级的模型。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: This study investigated the value of multiparametric MRI (mpMRI) in predicting Gleason score (GS) upgrading and downgrading in radical prostatectomy (RP) compared with presurgical biopsy.
MATERIALS AND METHODS: Clinical and mpMRI data were retrospectively collected from 219 patients with prostate disease between January 2015 and December 2021. All patients underwent systematic prostate biopsy followed by RP. MpMRI included conventional diffusion-weighted and dynamic contrast-enhanced imaging. Multivariable logistic regression analysis was performed to analyze the factors associated with GS upgrading and downgrading after RP. Receiver operating characteristic curve analysis was used to estimate the area under the curve (AUC) to indicate the performance of the multivariable logistic regression models in predicting GS upgrade and downgrade after RP.
RESULTS: The GS after RP was upgraded, downgraded, and unchanged in 92, 43, and 84 patients, respectively. The AUCs of the clinical (percentage of positive biopsy cores [PBCs], time from biopsy to RP) and mpMRI models (prostate cancer [PCa] location, Prostate Imaging Reporting and Data System [PI-RADS] v2.1 score) for predicting GS upgrading after RP were 0.714 and 0.749, respectively. The AUC of the combined diagnostic model (age, percentage of PBCs, tPSA, PCa location, and PI-RADS v2.1 score) was 0.816, which was larger than that of the clinical factors alone (P < 0.001). The AUCs of the clinical (age, percentage of PBCs, ratio of free/total PSA [F/T]) and mpMRI models (PCa diameter, PCa location, and PI-RADS v2.1 score) for predicting GS downgrading after RP were 0.749 and 0.835, respectively. The AUC of the combined diagnostic model (age, percentage of PBCs, F/T, PCa diameter, PCa location, and PI-RADS v2.1 score) was 0.883, which was larger than that of the clinical factors alone (P < 0.001).
CONCLUSION: Combining clinical factors and mpMRI findings can predict GS upgrade and downgrade after RP more accurately than using clinical factors alone.
引用
- Zhang J, Xu L, Zhang G, et al. Multiparametric MRI to Predict Gleason Score Upgrading and Downgrading at Radical Prostatectomy Compared to Presurgical Biopsy. Korean J Radiol. 2025. PMID: 40169496. doi:10.3348/kjr.2024.1008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。